Catalyst Dossier · compiled by Celia 🧫

Biodexa Pharmaceuticals Plc (BDRX)

Pharmaceutical Preparations · market cap $691.0B · as of 2026-06-23

Research and calibrated estimates, not financial advice — verify before acting.

Next catalyst

2026-06-26

Earnings

Pipeline

programs

Upcoming events

next 90d+

Dossier

Ready

cached

Biodexa Pharmaceuticals Plc (BDRX) is a micro-cap pharmaceutical company with 13 employees, no identified lead asset, and no active pipeline disclosed in the available facts. The company trades at approximately $3.06 with a market cap of $691,002M — a figure that appears anomalous given the operational profile — and has an upcoming earnings release on 2026-06-26.

The catalyst path

2026-06-26Earningsimp 5/10

Pipeline

No pipeline data.

The full dossier is a Pro feature

Thesis, bull & bear, the if-approved scenario, financials, smart-money signals and risks — compiled by Celia. The catalyst path & pipeline above are free.

See Pro

Data from CatalystAlert (ClinicalTrials.gov, SEC EDGAR, openFDA, Financial Modeling Prep). Compiled by Celia. Not financial advice.